← Search

Data · dataset · 2026

Tislelizumab-jsgr

Listed in Virginia Open Data Portal

TEVIMBRA (tislelizumab-jsgr) is an intravenous injection used as an immunotherapy drug that blocks programmed death receptor-1 (PD-1) to help the immune system fight certain cancers.

Description

Manufactured by BeOne Medicines USA, Inc., it's available as a 10 mg/mL solution concentrate, approved under BLA761232 and marketed since March 2024. This information was generated using AI and is provided for informational and research purposes only.

Links

Where it is published

Documentation and papers

Catalogue records · 1

Topics

Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
Virginia Open Data Portal5ec294b0-f46f-49c0-9a4a-5edd1797f2d43 h agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].anzsrc:group:4206mapping · data virginia govvocabulary-mapper@1.0.0keywords['public-health']
concepts[field].local:field:engineeringmapping · data virginia govconnector:data_virginia_gov@1.0.0
concepts[field].local:field:medicine-healthmapping · data virginia govconnector:data_virginia_gov@1.0.0
created_datesource · data virginia govconnector:data_virginia_gov@1.0.0
descriptionsource · data virginia govconnector:data_virginia_gov@1.0.0/notes
publication_datesource · data virginia govconnector:data_virginia_gov@1.0.0
titlesource · data virginia govconnector:data_virginia_gov@1.0.0/title
updated_datesource · data virginia govconnector:data_virginia_gov@1.0.0